Dr. Stuart Hardy, MD

Dr. Hardy practices at Wilmington Ear Nose & Throat Assoc., P.a. in Wilmington, North Carolina.

Dr. Hardy's NPI, 1386608495, was assigned on April 14, 2006. Dr. Hardy graduated from University of North Carolina at Chapel Hill School of Medicine in 2001. Dr. Hardy holds North Carolina license 2006-00226.

Dr. Hardy's primary practice is Wilmington Ear Nose & Throat Assoc., P.a., at 2311 Delaney Rd, Wilmington, NC 28403-6012. The practice phone is (910) 762-8754.

Dr. Hardy's primary practice is Wilmington Ear Nose & Throat Assoc., P.a. in Wilmington, North Carolina. Dr. Hardy is also affiliated with Novant Health New Hanover Regional Medical Center. The medical group on file is Wilmington Ear Nose & Throat Associates, P.A.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hardy practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Hardy's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Hardy is licensed in North Carolina.

CMS data shows 3,478 Medicare services from Dr. Hardy across 20 procedure codes in 2024, for 1,390 Medicare patients. Medicare paid $200,143 for them. Every service was in an office.

CMS counts 1,390 Medicare patients who saw Dr. Hardy in 2024. The largest group is 65 to 74, with 601 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hardy's median patient age at 65, with 54% women.

In 2024, Dr. Hardy wrote 1,269 Medicare Part D claims for 531 patients. 98% of them were for generic drugs. CMS names the drug for 1,083 of them, across 21 drugs with 11 or more claims each, at $87,860 in total drug cost. In 2023, CMS named 885 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Hardy for performance year 2024, reported individually. Dr. Hardy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Hardy in 2017. Dr. Hardy's most frequent co-authors are Patrick David Maguire, MD, Charles Rogers Neal, MD and Andrew Michael Schreiber, MD.

CMS Open Payments shows 172 general payments to Dr. Hardy from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Inspire Medical Systems, Inc. paid the most, $1,140.

Dr. Hardy graduated from University of North Carolina at Chapel Hill School of Medicine in 2001.